• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Bioactive Products
    Catalog No. Information
    CFN99749 Acetylcorynoline

    1. Acetylcorynoline has anti-inflammatory properties, it also has potential to improve parkinson's disease, it may exert its effects by decreasing egl-1 expression to suppress apoptosis pathways and by increasing rpn5 expression to enhance the activity of proteasomes.
    2. Acetylcorynoline may be one of the potent immunosuppressive agents through the blockage of dendritic cells maturation and function.
    3. Acetylcorynoline has protective action against experimental liver injury in mice.
    CFN99788 Irisflorentin

    1. Irisflorentin has anti-inflammatory activity in lipopolysaccharides (LPS)-stimulated RAW 264.7 macrophages, it can markedly reduce the transcriptional and translational levels of inducible nitric oxide synthase (iNOS) as well as the production of NO, it also can significantly inhibit TNF-α, IL-1βand IL-6 at both the transcriptional and translational levels.
    2. Irisflorentin has potential to ameliorate Parkinson’s disease in Caenorhabditis elegans models, it may exert its effects by promoting rpn-3 expression to enhance the activity of proteasomes and down-regulating egl-1 expression to block apoptosis pathways.
    3. Irisflorentin modifies properties of mouse bone marrow-derived dendritic cells and reduces the allergic contact hypersensitivity responses, suggests that irisflorentin may as an immunotherapeutic adjuvant.
    CFN99800 Levodopa

    1. Levodopa and HSYA reduced the likelihood of wearing off development, and may thus support the utility of such compounds for the improved treatment of PD.
    2. Levodopa's toxic effects masks the potential ability of HP-β-CD via complexation.
    CFN99925 Schisantherin A

    1. Schisantherin A is a mechanism-based inhibitor that not only competitively inhibits but irreversibly inactivates CYP3A4.
    2. Schisantherin A has anti-hepatotoxic, antioxidant and anti-tumoural activities.
    CFN90004 Rasagiline mesylate

    1. Rasagiline mesylate (TVP-1012) is a potent, selective, non-reversible MAO-B inhibitor, without the tyramine-potentiating effect and with neuroprotective activities, with anti-Parkinson activity.
    2. Rasagiline mesylate exhibits neuroprotective and anti-apoptotic activity against several neurotoxins in cell culture.